# Filing Detail

Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001104659-20-127387
Filing Date
2020-11-19
Accepted
2020-11-19 16:43:03
Documents
29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 424B4 | tm2027048-15_424b4.htm | 424B4 | 3243879
2 | GRAPHIC | lg_olemaoncology-bw.jpg | GRAPHIC | 54561
3 | GRAPHIC | tm2027048d4-tbl_overview4c.jpg | GRAPHIC | 548199
4 | GRAPHIC | tm2027048d1-pc_breast4c.jpg | GRAPHIC | 477458
5 | GRAPHIC | tm2027048d1-fc_avail4c.jpg | GRAPHIC | 34790
6 | GRAPHIC | tm2027048d1-fc_ertripar4clr.jpg | GRAPHIC | 27511
7 | GRAPHIC | tm2027048d1-fc_class4c.jpg | GRAPHIC | 26883
8 | GRAPHIC | tm2027048d1-fc_partial4c.jpg | GRAPHIC | 929019
9 | GRAPHIC | tm2027048d1-fc_ceranl4c.jpg | GRAPHIC | 1561756
10 | GRAPHIC | tm2027048d1-lc_cama4c.jpg | GRAPHIC | 514499
11 | GRAPHIC | tm2027048d1-bc_ovarie4c.jpg | GRAPHIC | 614998
12 | GRAPHIC | tm2027048d1-bc_op12504c.jpg | GRAPHIC | 1350440
13 | GRAPHIC | tm2027048d1-lc_op1250er4c.jpg | GRAPHIC | 181872
14 | GRAPHIC | tm2027048d1-lc_op12504c.jpg | GRAPHIC | 165383
15 | GRAPHIC | tm2027048d1-bc_hci12t4c.jpg | GRAPHIC | 119936
16 | GRAPHIC | tm2027048d1-lc_hci12b4c.jpg | GRAPHIC | 181953
17 | GRAPHIC | tm2027048d1-bc_hcc1500lef4c.jpg | GRAPHIC | 659426
18 | GRAPHIC | tm2027048d1-bc_hcc1500rig4c.jpg | GRAPHIC | 992837
19 | GRAPHIC | tm2027048d1-bc_st941left4c.jpg | GRAPHIC | 945432
20 | GRAPHIC | tm2027048d1-bc_st941right4c.jpg | GRAPHIC | 1535684
21 | GRAPHIC | tm2027048d1-bc_hct13bl4c.jpg | GRAPHIC | 134307
22 | GRAPHIC | tm2027048d1-lc_hct13br4c.jpg | GRAPHIC | 190270
23 | GRAPHIC | tm2027048d1-lc_brainmets4c.jpg | GRAPHIC | 152881
24 | GRAPHIC | tm2027048d1-lc_meantum4c.jpg | GRAPHIC | 164535
25 | GRAPHIC | tm2027048d1-lc_palbocic4c.jpg | GRAPHIC | 161775
26 | GRAPHIC | tm2027048d1-lc_abemacili4c.jpg | GRAPHIC | 156819
27 | GRAPHIC | tm2027048d1-lc_ribocicl4c.jpg | GRAPHIC | 171274
28 | GRAPHIC | tm2027048d1-lc_alpelisib4c.jpg | GRAPHIC | 166951
29 | GRAPHIC | tm2027048d4-fc_doseescal4c.jpg | GRAPHIC | 47233
| Complete submission text file | 0001104659-20-127387.txt |  | 18748230

Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-249748 | Film No.: 201329310
SIC: 2834 Pharmaceutical Preparations